Pfizer Inc (PFE) 35.44 $PFE Pfizer Beats Estimates On

New Post Public Reply Private Reply Replies (0) Message Board

Jul 28, 2015 at 3:11 PM

Pfizer Inc (PFE) 35.44 $PFE

Pfizer Beats Estimates On Strong Cancer Drug Sales
at The Street - 10 mins ago
Pfizer reported earnings that beat estimates and raised its outlook for the year, as its newly launched drug treatments continued to perform well in the second quarter.
PFE: 35.44 (+1.10)

Stocks Rally as Crude Oil Closes Near $48
at The Street - 11 mins ago
Stocks move confidently higher on Tuesday as the Federal Reserve kicks off a two-day meeting and crude oil prices rebound.
F: 14.90 (+0.35), BIDU: 163.32 (-34.36), PFE: 35.44 (+1.10), XOM: 82.51 (+3.25), COP: 52.58 (+1.93), BP: 37.27 (+1.22), CVX: 92.46 (+3.32), PTR: 99.30 (+4.13), UPS: 100.25 (+5.13), XLE: 70.55 (+2.04)

Drugmaker Pfizer tops Street 2Q forecasts, raises forecast
By LINDA A. JOHNSON - AP - 1 hr 35 mins ago
Pfizer Inc. beat Wall Street's second-quarter expectations and raised its 2015 forecast, as soaring sales for a few key products helped inoculate the world's second-largest drugmaker against a $1 billion revenue hit from foreign exchange rates and its last wave of cheap generic competition hurting former big sellers.
MRK: 57.26 (+0.27), PFE: 35.44 (+1.10), BMY: 64.53 (+0.23)

Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal
at Investor's Business Daily - 2 hrs 8 mins ago
Big pharmas Pfizer (PFE) and Merck (MRK) both beat Q2 estimates and raised guidance Tuesday, while Merck and French counterpart Sanofi (SNY) entered into separate deals to develop immunotherapy drugs for cancer. Pfizer's earnings dipped 3% to 56...
MRK: 57.26 (+0.27), PFE: 35.44 (+1.10), BMY: 64.53 (+0.23), SNY: 53.64 (+0.31), REGN: 555.68 (+15.65)

Stocks Turn Positive as Energy Sector Leads
at The Street - Tue Jul 28, 10:07AM CDT
Stocks bounce back to session highs by late morning Tuesday.
AMZN: 527.11 (-4.30), F: 14.90 (+0.35), HON: 104.42 (+2.78), PFE: 35.44 (+1.10), XOM: 82.51 (+3.25), COP: 52.58 (+1.93), UPS: 100.25 (+5.13), BIDU: 163.32 (-34.36), EBAY: 28.24 (+0.24), MRK: 57.26 (+0.27), DD: 56.00 (-0.73), BP: 37.27 (+1.22), PG: 80.43 (+0.46), CVX: 92.46 (+3.32), PTR: 99.30 (+4.13), XLE: 70.55 (+2.04)

China, the Fed Coming to Grips - Ahead of Wall Street
Sheraz Mian - Zacks Investment Research - Tue Jul 28, 9:27AM CDT
Stocks appear on track to start today's session in the green with a less-worrisome Chinese stock market, the Fed meeting and a barrage of earnings reports providing a mixed backdrop.
PFE: 35.44 (+1.10), DD: 56.00 (-0.73), UPS: 100.25 (+5.13)

Pfizer (PFE) Stock Climbs on Strong Earnings
at The Street - Tue Jul 28, 8:45AM CDT
Pfizer (PFE) shares are gaining after the company reported a drop in profit and revenues that still beat analysts' expectations.
PFE: 35.44 (+1.10)

Critical Alerts For ConocoPhillips, Teva, Pfizer Inc., Twitter and Invensense Released By InvestorsObserver
PR Newswire - Tue Jul 28, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for COP, TEVA, PFE, TWTR and INVN.
PFE: 35.44 (+1.10), INVN: 13.52 (+0.63), COP: 52.58 (+1.93), TEVA: 70.95 (-1.05), TWTR: 36.15 (+1.45)

Pfizer Beats on Q2 Earnings and Revenues, Revises Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Jul 28, 8:19AM CDT
Pfizer (PFE) raised the midpoint of its 2015 guidance range for revenues by $500 million and for earnings by 4 cents.
BAX: 38.08 (+0.38), PFE: 35.44 (+1.10), LLY: 85.59 (+1.44), HSP: 89.24 (-0.11)

Stock Futures Trade Higher as U.S. Home Prices Climb
at The Street - Tue Jul 28, 8:13AM CDT
Stock futures hold onto gains on Tuesday as home prices rise in May, though at a slightly slower pace than expected.
AMZN: 527.11 (-4.30), F: 14.90 (+0.35), HON: 104.42 (+2.78), PFE: 35.44 (+1.10), BIDU: 163.32 (-34.36), EBAY: 28.23 (+0.23), MRK: 57.26 (+0.27), DD: 56.00 (-0.73), BP: 37.27 (+1.22), PG: 80.43 (+0.46)

Pfizer (PFE) Beats on Q2 Earnings and Revenues - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 28, 7:36AM CDT
Pfizer (PFE) Beats on Q2 Earnings and Revenues
PFE: 35.44 (+1.10)

Are These 2 Big Pharmas Really Buyout Candidates?
George Budwell, The Motley Fool - Motley Fool - Tue Jul 28, 6:42AM CDT
Source: Pixabay The pharmaceutical industry is undergoing an unprecedented amount of consolidation right now due to an influx of cash from several new classes of drugs and the need to replace former blockbusters that have lost patent...
GILD: 112.47 (+1.93), PFE: 35.44 (+1.10), AZN: 32.85 (+0.14), BMY: 64.53 (+0.23)

PFIZER REPORTS SECOND-QUARTER 2015 RESULTS
Business Wire - Tue Jul 28, 6:00AM CDT
--Second-Quarter 2015 Adjusted Diluted EPS(2) of $0.56, Reported Diluted EPS(1) of $0.42
PFE: 35.44 (+1.10)

Fed Meeting, Twitter Earnings, Consumer Data in Focus Tuesday
at The Street - Mon Jul 27, 7:15PM CDT
Merck, Pfizer, UPS and Twitter are among the many companies reporting earnings.
F: 14.90 (+0.35), PNRA: 184.54 (+0.53), GILD: 112.47 (+1.93), PFE: 35.44 (+1.10), MRK: 57.26 (+0.27), DD: 56.00 (-0.73), TWTR: 36.15 (+1.45), BWLD: 170.33 (+1.76), UPS: 100.25 (+5.13)

What's in Store for Hospira (HSP) this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 3:20PM CDT
Hospira Inc. (HSP) is set to report second-quarter 2015 results on Jul 29 before the market opens.
IMDZ: 23.27 (+0.14), MDCO: 33.63 (+0.24), PFE: 35.44 (+1.10), HSP: 89.24 (-0.11)

Will Currency & Generics Weigh on Pfizer (PFE) Q2 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 3:10PM CDT
Pfizer (PFE), which is scheduled to report its second-quarter 2015 earnings on Jul 28, had posted a positive earnings surprise of 2.00% last quarter.
MDCO: 33.63 (+0.24), PFE: 35.44 (+1.10), TEVA: 70.95 (-1.05), HSP: 89.24 (-0.11)

Will Headwinds Weigh on Glaxo's (GSK) Earnings in Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 2:50PM CDT
Glaxo (GSK), which is scheduled to report its second-quarter 2015 earnings on Jul 29, had posted a negative earnings surprise of 12.73% last quarter.
PRGO: 191.04 (-2.56), PFE: 35.44 (+1.10), GSK: 41.72 (+0.12), NVS: 102.80 (+1.26)

Pfizer (PFE) Stock Falls Ahead of Earnings Release
at The Street - Mon Jul 27, 10:43AM CDT
Pfizer (PFE) shares are declining ahead of tomorrow's release of the company's second quarter earnings results.
PFE: 35.44 (+1.10)

Norfolk Southern, Roper Industries, Pfizer, Merck and IBM are part of Zacks Earnings Preview: - Press Releases
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 8:30AM CDT
Norfolk Southern, Roper Industries, Pfizer, Merck and IBM are part of Zacks Earnings Preview:
ROP: 164.86 (+0.61), MRK: 57.26 (+0.27), PFE: 35.44 (+1.10), DD: 56.00 (-0.73)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Beef 'O' Brady's Expands Into Tuscaloosa Market

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Layne's Chicken Fingers Expands with Brownsville Opening

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Portillo's Faces Class Action: Investor Losses at Stake

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...